ReviewChemical & biomedical imaging2026
Molecular Engineering of Porphyrins for Near-Infrared Bioimaging and Phototherapy.
Review in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Imaging from Macro to Nanoscale: Multimodal Advances in Chemical and Biomedical Imaging.Chemical & biomedical imaging · 2026Review
- Triply N-Confused Hexaphyrins(1.1.1.1.1.0) Synthesized From N-Confused Hexaphyrin(2.1.1.1.1.1): Aromaticity Modulation, Metal Coordination, and Photothermal Conversion.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porphyrins represent fundamental molecules in phototherapy, with their derivatives clinically approved as photosensitizers for photodynamic therapy (PDT). Their applications have expanded from traditional fluorescence imaging and PDT to diverse approaches, including photoacoustic imaging and photothermal therapy. Compared with visible light, near-infrared (NIR) light offers enhanced safety and efficiency in phototheranostics due to its greater tissue penetration depth. However, conventional porphyrins lack NIR absorption; furthermore, they suffer from aggregation-caused quenching and limited photostability. This review systematically summarizes recent advances in addressing these problems through molecular design of porphyrins, employing ligand π-system engineering, metal coordination, and nanoassembly to achieve precise control over their photophysical properties. We focus on achieving bathochromic shifts with enhanced intensity in absorption/emission spectra in porphyrins and on regulating energy conversion pathways to selectively improve NIR luminescence, reactive oxygen species generation, or photothermal conversion. These advances facilitate the development of highly efficient and controllable NIR-activatable agents, highlighting the promising role of porphyrin-based materials and paving the way for their clinical translation in precision multifunctional phototheranostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.